Martin Filipits
Institute of Cancer Research
Department of Medicine I
Medical University of Vienna
Borschkegasse 8a
Austria
Name/email consistency: high
- Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy. Filipits, M., Rudas, M., Heinzl, H., Jakesz, R., Kubista, E., Lax, S., Schippinger, W., Dietze, O., Greil, R., Stiglbauer, W., Kwasny, W., Nader, A., Stierer, M., Gnant, M.F. Clin. Cancer Res. (2009)
- Clinical relevance of monoclonal antibodies in non small cell lung cancer. Filipits, M. J. BUON (2009)
- Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program. Filipits, M., Haddad, V., Schmid, K., Huynh, A., Dunant, A., André, F., Brambilla, E., Stahel, R., Pignon, J.P., Soria, J.C., Popper, H.H., Le Chevalier, T., Pirker, R. Clin. Cancer Res. (2007)
- Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program. Filipits, M., Pirker, R., Dunant, A., Lantuejoul, S., Schmid, K., Huynh, A., Haddad, V., André, F., Stahel, R., Pignon, J.P., Soria, J.C., Popper, H.H., Le Chevalier, T., Brambilla, E. J. Clin. Oncol. (2007)
- Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group. Filipits, M., Pohl, G., Rudas, M., Dietze, O., Lax, S., Grill, R., Pirker, R., Zielinski, C.C., Hausmaninger, H., Kubista, E., Samonigg, H., Jakesz, R. J. Clin. Oncol. (2005)